SPP1 and type 2 diabetes mellitus: Given that osteopontin is known to regulate bone mineralisation, and that recent findings indicate its association with T2DM, it is plausible that osteopontin may be a novel mediator regulating both skeletal and glucose metabolic homeostasis.